73 related articles for article (PubMed ID: 16188246)
1. Apoptosis of multiple myeloma cells induced by agonist monoclonal antibody against human CD28.
Qiu YH; Sun ZW; Shi Q; Su CH; Chen YJ; Shi YJ; Tao R; Ge Y; Zhang XG
Cell Immunol; 2005; 236(1-2):154-60. PubMed ID: 16188246
[TBL] [Abstract][Full Text] [Related]
2. Immunomodulatory properties of FK734, a humanized anti-CD28 monoclonal antibody with agonistic and antagonistic activities.
Shiao SL; McNiff JM; Masunaga T; Tamura K; Kubo K; Pober JS
Transplantation; 2007 Feb; 83(3):304-13. PubMed ID: 17297405
[TBL] [Abstract][Full Text] [Related]
3. [Study on proliferation inhibiting and apoptosis inducing effects of cerulenin on multiple myeloma cells].
Wang WQ; Zhao XY; Xu GB; Liang Y
Zhonghua Xue Ye Xue Za Zhi; 2006 Oct; 27(10):675-7. PubMed ID: 17343199
[TBL] [Abstract][Full Text] [Related]
4. Increased susceptibility to apoptosis in CD45(+) myeloma cells accompanied by the increased expression of VDAC1.
Liu S; Ishikawa H; Tsuyama N; Li FJ; Abroun S; Otsuyama KI; Zheng X; Ma Z; Maki Y; Iqbal MS; Obata M; Kawano MM
Oncogene; 2006 Jan; 25(3):419-29. PubMed ID: 16247487
[TBL] [Abstract][Full Text] [Related]
5. All-trans retinoic acid can intensify the growth inhibition and differentiation induction effect of rosiglitazone on multiple myeloma cells.
Huang H; Wu D; Fu J; Chen G; Chang W; Chow HC; Leung AY; Liang R
Eur J Haematol; 2009 Sep; 83(3):191-202. PubMed ID: 19467017
[TBL] [Abstract][Full Text] [Related]
6. Systemic anti-hepatocyte growth factor monoclonal antibody therapy induces the regression of intracranial glioma xenografts.
Kim KJ; Wang L; Su YC; Gillespie GY; Salhotra A; Lal B; Laterra J
Clin Cancer Res; 2006 Feb; 12(4):1292-8. PubMed ID: 16489086
[TBL] [Abstract][Full Text] [Related]
7. Suppression of T-lymphoma cell apoptosis by monoclonal antibodies raised against cell surface adhesion molecules.
Fujita N; Kataoka S; Naito M; Heike Y; Boku N; Nakajima M; Tsuruo T
Cancer Res; 1993 Oct; 53(20):5022-7. PubMed ID: 8402694
[TBL] [Abstract][Full Text] [Related]
8. [Cytotoxic mechanism of anti-human death receptor 5 monoclonal antibody mDRA-6].
Liu GC; Ma YF; Zhang J; Li SL; Lu F; Bai HL; Zhao YP
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2006 Nov; 22(6):790-3. PubMed ID: 17077022
[TBL] [Abstract][Full Text] [Related]
9. A novel anti-human syndecan-1 (CD138) monoclonal antibody 4B3: characterization and application.
Sun WP; Wang FM; Xie F; Wang GQ; Sun J; Yu GH; Qiu YH; Zhang XG
Cell Mol Immunol; 2007 Jun; 4(3):209-14. PubMed ID: 17601375
[TBL] [Abstract][Full Text] [Related]
10. Antibody-mediated signaling through PD-1 costimulates T cells and enhances CD28-dependent proliferation.
del Rio ML; Penuelas-Rivas G; Dominguez-Perles R; Ramirez P; Parrilla P; Rodriguez-Barbosa JI
Eur J Immunol; 2005 Dec; 35(12):3545-60. PubMed ID: 16285013
[TBL] [Abstract][Full Text] [Related]
11. Impaired interleukin-2 synthesis and T cell proliferation following antibody-mediated CD3 and CD2 or CD28 cross-linking in trans: evidence that T cell activation requires the engagement of costimulatory molecules within the immunological synapse.
Watson CL; Furlong SJ; Hoskin DW
Immunol Invest; 2008; 37(1):63-78. PubMed ID: 18214800
[TBL] [Abstract][Full Text] [Related]
12. [Cerulenin changes apoptosis related genes expression in multiple myeloma cell line U266].
Wang WQ; Zhao XY; Gong XB; Zhang XH
Zhonghua Xue Ye Xue Za Zhi; 2007 Apr; 28(4):239-42. PubMed ID: 17877200
[TBL] [Abstract][Full Text] [Related]
13. Effective treatment of adjuvant arthritis with a stimulatory CD28-specific monoclonal antibody.
Rodríguez-Palmero M; Franch A; Castell M; Pelegrí C; Pérez-Cano FJ; Kleinschnitz C; Stoll G; Hünig T; Castellote C
J Rheumatol; 2006 Jan; 33(1):110-8. PubMed ID: 16395758
[TBL] [Abstract][Full Text] [Related]
14. Induction of CD28 on the new myeloma cell line MOLP-8 with t(11;14)(q13;q32) expressing delta/lambda type immunoglobulin.
Matsuo Y; Drexler HG; Harashima A; Okochi A; Hasegawa A; Kojima K; Orita K
Leuk Res; 2004 Aug; 28(8):869-77. PubMed ID: 15203285
[TBL] [Abstract][Full Text] [Related]
15. Anti-CD26 monoclonal antibody-mediated G1-S arrest of human renal clear cell carcinoma Caki-2 is associated with retinoblastoma substrate dephosphorylation, cyclin-dependent kinase 2 reduction, p27(kip1) enhancement, and disruption of binding to the extracellular matrix.
Inamoto T; Yamochi T; Ohnuma K; Iwata S; Kina S; Inamoto S; Tachibana M; Katsuoka Y; Dang NH; Morimoto C
Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3470-7. PubMed ID: 16740772
[TBL] [Abstract][Full Text] [Related]
16. A single-chain Fv diabody against human leukocyte antigen-A molecules specifically induces myeloma cell death in the bone marrow environment.
Sekimoto E; Ozaki S; Ohshima T; Shibata H; Hashimoto T; Abe M; Kimura N; Hattori K; Kawai S; Kinoshita Y; Yamada-Okabe H; Tsuchiya M; Matsumoto T
Cancer Res; 2007 Feb; 67(3):1184-92. PubMed ID: 17283154
[TBL] [Abstract][Full Text] [Related]
17. Immunomodulatory drug lenalidomide (CC-5013, IMiD3) augments anti-CD40 SGN-40-induced cytotoxicity in human multiple myeloma: clinical implications.
Tai YT; Li XF; Catley L; Coffey R; Breitkreutz I; Bae J; Song W; Podar K; Hideshima T; Chauhan D; Schlossman R; Richardson P; Treon SP; Grewal IS; Munshi NC; Anderson KC
Cancer Res; 2005 Dec; 65(24):11712-20. PubMed ID: 16357183
[TBL] [Abstract][Full Text] [Related]
18. [Monoclonal antibody against brain derived neurotrophic factor inhibits myeloma growth and angiogenesis in the xenograft NOD/SCID animal model].
Wang YD; Hu Y; Zhang L; Huang J; Sun CY
Zhonghua Xue Ye Xue Za Zhi; 2007 Oct; 28(10):659-63. PubMed ID: 18399169
[TBL] [Abstract][Full Text] [Related]
19. Susceptibility to Fas and tumor necrosis factor-alpha receptor mediated apoptosis of anti-CD3/anti-CD28-activated umbilical cord blood T cells.
Lin SJ; Lee CC; Cheng PJ; See LC; Kuo ML
Pediatr Allergy Immunol; 2009 Jun; 20(4):392-8. PubMed ID: 18713315
[TBL] [Abstract][Full Text] [Related]
20. mHFE7A, a newly identified monoclonal antibody to Fas, induces apoptosis in human melanoma cells in vitro and delays the growth of melanoma xenotransplants.
Hiramoto K; Inui M; Kamei T; Okumura K; Nakase M; Tagawa T
Oncol Rep; 2006 Feb; 15(2):409-15. PubMed ID: 16391862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
